Heartflow (HTFL) Rockets 46%: What Analysts Say and Where Hedge Funds Stand
Heartflow Inc. (NASDAQ:HTFL) rose about 46% week-on-week after reporting Q2 revenue up 48% to $64.08 million. Net loss widened to $15.7 million. For 2026, the company raised revenue growth guidance to 40% to 42%, or $246 million to $250 million. Stifel and JPMorgan lifted price targets to $45; Wells Fargo raised to $39.
How this was made
The 30-second read
Why it matters
The updated quarterly revenue performance and raised full-year growth outlook are the core catalysts, reinforced by analyst target increases. However, the larger net loss suggests execution and cost discipline remain key swing factors for valuation.
Market read
Traders can use the guidance raise and Q2 revenue beat as a near-term catalyst, while monitoring net-loss trajectory for downside risk.
What to watch
Investors may focus on whether gross margin and operating leverage improvements persist, and whether Plaque and FFR growth can offset higher pre-tax losses.
Background
Heartflow is a US-listed cardiovascular diagnostics company with an FFR business and an emerging Plaque revenue stream, positioned around AI-enabled CAD detection and management.
Ticker impact
Heartflow reported Q2 revenue up 48% to $64.08M and raised full-year revenue growth outlook to 40% to 42% ($246M to $250M).
Near-term upside bias with volatility likely due to net-loss deterioration.
The article discloses a specific guidance upgrade and Q2 revenue beat, which typically drives momentum, while the 70.6% net-loss widening can cap enthusiasm for profitability-focused traders.
Market effects
Signals continued demand and under-penetration narrative in coronary artery disease diagnostics, potentially supporting sentiment for adjacent medtech/AI diagnostics names.
Primarily US small-cap growth sentiment, with potential spillover to US-listed medtech peers.
Limited direct global impact; mostly affects US-listed investors tracking CAD diagnostic platforms.
Counterpoint
The stock’s 46% week-on-week move may be overextended relative to profitability, since net loss widened sharply despite revenue growth.
Key entities
- companyHeartflow Inc.
NASDAQ:HTFL, reported Q2 revenue growth and raised full-year revenue guidance while net loss widened.
- executiveJohn Farquhar
CEO who attributed growth to category leadership, AI platform, and under-penetrated CAD detection market.
- analyst_firmStifel
Raised price target to $45 from $40 and maintained a buy rating.
- analyst_firmJPMorgan
Raised price target to $45 from $35 and maintained an overweight rating.
- analyst_firmWells Fargo
Upgraded price target to $39 from $37, citing potential upside versus guidance.
